THE USE OF COMPLETE BLOOD COUNT AS INFLAMMATORY BIOMARKERS IN PATIENTS WITH GASTRIC CANCER IN ENUGU STATE UNIVERSITY OF SCIENCE AND TECHNOLOGY TEACHING HOSPITAL, PARKLANE ENUGU

A complete blood count (CBC) is a standard investigation required from all gastric cancer patients before treatment and during treatment. Poor CBC parameters may negatively affect cancer outcomes. This present study investigated the use of Complete Blood Count (CBC) and Erythrocyte Sedimentation Rate (ESR) as an assessment of inflammation in these subjects. The study comprised of 54 male and female subjects and 54 controls with ages between 21-70 years. A longitudinal study method was used.